Patients who receive umbilical cord blood transplants for blood cancers now live equally long regardless of their race, new research from UVA Cancer Center shows.
Andreessen Horowitz-backed startup lands $200M for AI-based drug discovery
Genesis Therapeutics, a startup using artificial intelligence to design small molecule drugs, has raised $200 million in Series B financing — one of the largest